AMILORIDE AND ITS ANALOGS AS TOOLS IN THE STUDY OF ION-TRANSPORT

被引:1258
作者
KLEYMAN, TR
CRAGOE, EJ
机构
[1] COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032
[2] MERCK SHARP & DOHME RES LABS,W POINT,PA 19486
关键词
D O I
10.1007/BF01871102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1 / 21
页数:21
相关论文
共 85 条
[1]   MODIFIER ROLE OF INTERNAL H+ IN ACTIVATING THE NA+-H+ EXCHANGER IN RENAL MICROVILLUS MEMBRANE-VESICLES [J].
ARONSON, PS ;
NEE, J ;
SUHM, MA .
NATURE, 1982, 299 (5879) :161-163
[2]   PURIFICATION AND SUBUNIT STRUCTURE OF THE [H-3] PHENAMIL RECEPTOR ASSOCIATED WITH THE RENAL APICAL NA+ CHANNEL [J].
BARBRY, P ;
CHASSANDE, O ;
VIGNE, P ;
FRELIN, C ;
ELLORY, C ;
CRAGOE, EJ ;
LAZDUNSKI, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (14) :4836-4840
[3]   AMILORIDE - A MOLECULAR PROBE OF SODIUM-TRANSPORT IN TISSUES AND CELLS [J].
BENOS, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (03) :C131-C145
[4]   AMILORIDE FLUXES ACROSS ERYTHROCYTE-MEMBRANES [J].
BENOS, DJ ;
REYES, J ;
SHOEMAKER, DG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 734 (01) :99-104
[5]  
BENOS DJ, 1987, J BIOL CHEM, V262, P10613
[6]   EFFECT OF AMILORIDE AND SOME OF ITS ANALOGS ON CATION-TRANSPORT IN ISOLATED FROG SKIN AND THIN LIPID-MEMBRANES [J].
BENOS, DJ ;
SIMON, SA ;
MANDEL, LJ ;
CALA, PM .
JOURNAL OF GENERAL PHYSIOLOGY, 1976, 68 (01) :43-63
[7]   PURIFICATION AND CHARACTERIZATION OF THE AMILORIDE-SENSITIVE SODIUM-CHANNEL FROM A6 CULTURED-CELLS AND BOVINE RENAL PAPILLA [J].
BENOS, DJ ;
SACCOMANI, G ;
BRENNER, BM ;
SARIBANSOHRABY, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8525-8529
[8]   AMILORIDE - A POTENT INHIBITOR OF SODIUM TRANSPORT ACROSS TOAD BLADDER [J].
BENTLEY, PJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1968, 195 (02) :317-&
[9]  
BESTERMAN JM, 1985, J BIOL CHEM, V260, P1155
[10]   COMPETITIVE INTERACTION OF AMILORIDE AND VERAPAMIL WITH ALPHA-1-ADRENOCEPTORS IN VASCULAR SMOOTH-MUSCLE [J].
BHALLA, RC ;
SHARMA, RV .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (05) :927-932